Medicare Price Negotiation Idea Gaining Ground

Allowing Medicare to negotiate drug prices with pharma may soon become policy. A growing number of legislators have publicly expressed support for this and other pieces of policy that would reduce healthcare costs. As expected, pharma is strongly opposed to such legislation.

“Negotiating Medicare drug prices is the linchpin of President Joe Biden’s ambitious health care agenda. Not only would consumers see lower costs, but savings would be plowed into other priorities such as dental coverage for retirees and lower premiums for people with plans under the Obama-era health law.” Read more here.

(Source: Ricardo Alonso- Zalvidar, The Associated Press, 10/6/21)